The time to noncurative recurrence after liver resection as an appropriate surrogate measure for overall survival in patients with hepatocellular carcinoma
- 12 February 2025
- journal article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 29 (4) , 101989
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinomaHepatology, 2023
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 updateJournal of Hepatology, 2021
- Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 updateHepatology Research, 2019
- Time-to-Interventional Failure as a New Surrogate Measure for Survival Outcomes after Resection of Hepatocellular CarcinomaJournal of Gastrointestinal Surgery, 2019
- Surgery for Recurrent Hepatocellular CarcinomaAnnals of Surgery, 2019
- Survival following redo hepatectomy vs radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysisHPB, 2017
- Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 updateHepatology International, 2016
- The Feasibility of Third or More Repeat Hepatectomy for Recurrent Hepatocellular CarcinomaAnnals of Surgery, 2015
- Evidence‐based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH‐HCC Guidelines)Hepatology Research, 2015
- Second hepatic resection for recurrent hepatocellular cancer: A Western experienceJournal of Hepatology, 2011